Semaglutide Drugs Show Potential Beyond Weight Loss

New research suggests Ozempic and Wegovy may aid in smoking cessation, but further studies are needed.

Semaglutide, the active ingredient in Ozempic and Wegovy, may help reduce tobacco cravings.
A study found smokers with type 2 diabetes using semaglutide had fewer tobacco-related medical encounters.
Researchers observed a lower need for smoking cessation medications and counseling among semaglutide users.
The findings indicate potential for semaglutide in treating tobacco use disorder, though more clinical trials are required.
The exact mechanisms by which semaglutide affects addiction behaviors remain unclear.